Chronic inflammation has been implicated as the underlying mechanism responsible for the pathophysiology of preterm labour. Mannose-binding lectin (MBL) plays a central role in the innate immune response and is thus an important component of the first line of defense. The aim of this study was to investigate whether serum concentrations of MBL correlated with the incidence of preterm birth and low birthweight in a cohort of women with signs of threatened preterm birth. A cohort of 60 patients who presented with regular contractions and/or short cervix (group A) between 24 and 32 weeks of gestation and 20 healthy controls (group B) who had no pregnancy complications and delivered at term were recruited into a prospective study. The following outcomes were recorded: presence of preterm labour and birthweight in all patients. MBL and high sensitivity C-reactive protein levels were measured in all serum samples. The serum concentrations of MBL were significantly reduced in patients with threatened preterm labour (Group A), compared to the control Group B. Furthermore, infants born to Group A mothers with MBL deficiency (n = 13, MBL ≤100 ng/mL) had significantly lower birthweights, compared to those born to Group A women with normal MBL serum concentrations (P < .0001). Our small cohort study demonstrated a strong association between MBL deficiency and preterm delivery, and associated low birthweight. MBL deficiency could thus be considered an important risk factor for preterm birth.
| INTRODUCTION
Preterm birth, the leading cause of neonatal mortality and morbidity worldwide, presents a serious medical and socioeconomic problem. Chronic inflammation has been implicated as the underlying mechanism responsible for the pathophysiology of preterm labour. 1 The aetiology of preterm labour is heterogeneous. Clinical symptoms of spontaneous preterm labour include regular contractions and preterm premature rupture of membranes (PPROM). Spontaneous preterm birth is defined by regular contractions and concurrent progressive cervical changes (ie cervical dilation >3 cm). Short cervical length (<25 mm) is a significant preclinical predisposing factor for preterm labour and/or PPROM. Cervical shortening below 15 mm increases the risk of preterm delivery before 33 weeks to 50%. 2, 3 Infection is a frequent and very important mechanism of disease in preterm labour. 3 In addition, innate and adaptive immune system response is likely to play a role in mediating preterm labour. Recent studies also suggest that maternal microbiome and its interactions with the maternal and foetal immune system could play a role in the process of preterm labour. 4 The complement system is the backbone of the innate immune system, which enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism. It is involved in many diverse processes involving antimicrobial defense, immune complex clearance and tissue regeneration. The activation of the innate immune system is mediated by receptors that recognize pathogen-associated molecular patterns and bring about inflammatory responses. The complement system consists of a series of >50 proteins, which get activated through an amplifying cascade of protease cleavages. The end result of the complement activation cascade is stimulation of phagocytes to clear pathogenic micro-organisms and foreign and tumour cells via opsonization, chemotaxis, inflammation and cell lysis, coagulation and antibody production. The complement can be activated via three different pathways, the classical pathway, which is triggered by antibody or by direct binding of C1q to the pathogen surface, alternative pathway, which is triggered directly on pathogen surfaces and the mannose-binding lectin (MBL) pathway, which is triggered by MBL, a serum constituent that binds some encapsulated bacteria. The complement consists of nine serum proteins, C1-9, Factors B, P, D, H and I, MBL and MBL-associated serum proteases, MASP-1 and MASP-2. Independent of the mechanism of activation, all pathways converge to generate C3 convertases that cleave C3 into its active components, C3a and C3b. 5 MBL (C-type serum lectin) is a soluble oligomeric collectin protein. Collectins belong to a family of evolutionarily conserved mammalian pattern recognition molecules. The main function of MBL and other collectins is to bind oligosaccharide structures on the surface of micro-organisms. The binding recognizes self and non-self and it facilitates microbial elimination via phagocytosis, opsonization, complement activation, microbial aggregation or inhibition of bacterial propagation. It has been shown that collectins regulate inflammatory processes, host-pathogen interactions and immune tolerance. 6, 7 MBL plays a central role in the innate immune response and is thus an important component of the first line of defense. MBL binding to microbial surface carbohydrates can mediate opsonophagocytosis directly and by activation of the lectin complement pathway. 8 Unlike other collectins, MBL can activate the lectin complement pathway via MBL-associated serine proteases (MASPs), resulting in the cleavage of C2 and C4, which converge and activate C3. Patients with low levels of MBL are reported to be more susceptible to bacterial infections, intracellular pathogens (Mycobacterium, Legionella, Leishmania), some parasites and HIV infection. In addition, the severity of these infections can be more pronounced. [9] [10] [11] MBL is synthesized in the liver. The gene for human MBL, MBL2, lies on chromosome 10. In addition to impairing immunity against micro-organisms, hereditary deficiencies of this system predispose to autoimmune conditions. 12, 13 birth, premature rupture of membranes and histological chorioamnionitis in patients with serum levels <100 ng/ mL. 22 However, others found no differences in the functional activity of MBL-MASP in preeclamptic patients vs controls. 24 Several studies investigated the role of MBL polymorphism and serum levels in preterm birth. 20,25 van de Geijn et al 20 found an association between the maternal high MBL genotype group A and premature birth, suggesting that during pregnancy MBL-associated inflammation caused by higher MBL activity may contribute to earlier delivery. In contrast, Wang et al 25 did not show any correlation between MBL concentrations and the length of gestation. The aim of this study was to investigate whether serum concentrations of MBL correlated with the incidence of preterm birth in a cohort of women with threatened preterm birth who had clinical (preterm contractions) and subclinical (short cervix) risk factors of preterm delivery.
| MATERIALS AND METHODS

| Patients
This was a prospective study, including a cohort of 60 patients with threatened preterm birth (Group A) and 20 healthy controls who had no pregnancy complications and delivered at term (Group B) ( Table 1) . Patients were recruited at the Department of Gynecology and Obstetrics of the General University Hospital and the 1st Faculty of Medicine, Charles University in Prague, between January 2013 and February 2014. All pregnant patients had singleton pregnancies. Group A patients were recruited between 24 and 32 weeks of gestation on the basis of the following criteria: (1) regular uterine contractions and/or (2) short cervix, defined as a cervical length ≤25 mm. 26 The following clinical outcomes were recorded: (1) delivery before 34 week gestation; (2) term delivery (>37 week); (3) chorioamnionitis (confirmed histologically after delivery); and (4) funisitis (confirmed histologically after delivery).
Birthweight was recorded in all patients. MBL and high sensitivity C-reactive protein (hs-CRP) levels were measured in all serum samples. The blood samples were obtained during admission in group A, or during prenatal care in group B to match the gestational age of the time of collection in both groups. Informed consent was obtained from all individuals included in this study. 
| Measurement of MBL and hs-CRP concentrations
Peripheral blood samples were collected from the cubital vein into additive-free tubes with a serum gel separator and centrifuged at 1008 g for 10 minutes within 20 minutes of blood draw. Serum aliquots were stored at À80°C until further analysis. MBL was quantified using the Quantikine Human MBL ELISA immunoassay (R&D Systems, USA) according to the manufacturer's instructions. CardioPhase hs-CRP Dade Behring (Siemens, Germany) was used to determine the levels of hs-CRP. This assay is based on particle-enhanced immunonephelometry. Expected values for healthy individuals are typically ≤3 mg/L.
| Cervical length measurement
The cervical length was measured using vaginal ultrasound (Acuson XP128, Mountain View, CA) by one certified sonographer (certification of the Fetal Medicine Centre, London, UK). Transvaginal cervical length measurements were obtained using the technique described by Iams et al. 27 
| Statistical analysis
The sample size was determined using Epi Info TM 6.04 freeware (Center of Disease Control and Prevention). Subsequent statistical analyses, including frequency distributions for categorical data and calculations of medians and interquartile ranges (IQR) for continuous variables, were performed using the STATISTICA CZ 12.0 software (StatSoft Inc, USA). Different groups of patients were compared using the Kruskal-Wallis nonparametric test. Spearman's rank correlation coefficient was used as a measure of the linear relationship between two sets of data. Results were considered significant at P ≤ .05.
| RESULTS
| Patient characteristics
Based on the annual birth rate in the Czech Republic (~100 000 newborns), and the rate of preterm delivery (~7% per annum), we calculated a minimum sample size of 53 patients (to achieve a 90% confidence level). Our cohort size of 60 patients with threatened preterm labour (Group A) was thus deemed sufficient for the purpose of this study. In the Group A, 34% patients delivered before 34 weeks of gestation, and 25% patients delivered after 37 weeks. The control Group B (n = 20) consisted of healthy pregnant women with physiologically ongoing pregnancy and subsequent term delivery. Patients and control subjects' details are summarized in Table 1 .
| MBL and hs-CRP serum concentrations
We analysed the serum concentrations of MBL and hs-CRP in both groups of women at around 26-27 week of gestation ( Table 2 ). The serum concentrations of MBL were significantly reduced in patients with threatened preterm labour (Group A), compared to the control Group B of patients who had uneventful pregnancies with term deliveries (582.5 ng/mL vs 884 ng/mL; P = .039, Table 2 ). There were 13 cases of absolute MBL deficiency (ie concentrations below 100 ng/mL) in Group A (22%), and not one case of such decreased MBL serum levels in Group B.
In addition, we assessed the concentrations of MBL in Group A patients in relation to the presence or absence of the two risk factors for preterm labour, that is uterine contractions and short cervical length (<15 mm). The concentration of MBL was significantly reduced in patients who experienced contractions, compared to those who did not (P = .0472; Figure 1A) ; and it was also significantly reduced in patients with severe cervical shortening (<15 mm) (P = .006; Figure 1B ). There were no statistically significant differences in the Hs-CRP concentrations between the two groups of patients.
| MBL serum levels and pregnancy outcomes
More than a third of patients in group A delivered preterm (<34 week; n = 21). In this subgroup, 8 mothers had histologically proven evidence of chorioamnionitis, and 3 of these patients additionally tested positive for funisitis. It is interesting to note that the levels of MBL in these three patients who tested positive for both chorioamnionitis and funisitis were severely reduced (<100 ng/mL in all; Figure 2) . Furthermore, infants born to Group A mothers with MBL deficiency (n = 13, MBL ≤100 ng/mL) had significantly lower birthweights, compared to those born to Group A women with normal MBL serum concentrations (P < .0001; Figure 3 ).
| DISCUSSION
The aim of this study was to analyse maternal serum concentrations of MBL in women with threatened preterm birth. We showed that low levels of MBL were associated with the risk of preterm delivery before 34 weeks of gestation, and with a lower birthweight, which is likely a consequence of the increased incidence of preterm delivery in these patients. In addition, low levels of MBL were associated with a high risk of chorioamnionitis and funisitis. Histological presence of funisitis is a feature of foetal inflammatory response, which is associated with increased neonatal morbidity. 28 There is no clear consensus in the literature regarding the association between MBL levels and preterm birth. Our results are in agreement with those of Calkavur et al 22 who showed increased incidence of preterm birth and spontaneous abortions in women with MBL deficit (defined as serum concentrations <100 ng/mL). The concentrations of MBL are dependent on individual's genotype and MBL2 polymorphism. MBL deficiency has been defined as serum levels <100 ng/mL (severe deficiency, occurs in~5% population) or <500 ng/mL (moderate deficiency, occurs in~30% population). 29 MBL deficiency has been associated with a large and heterogeneous group of 
F I G U R E 1 Serum concentrations of MBL in patients with
threatened preterm labour-(Group A, n = 60) in relation to the risk factors of preterm labour, that is the presence of uterine contractions (A) or short cervical length (<15 mm) (B). MBL-mannose-binding lectin. In box plots, the bottom and top of boxes are the first and third quartiles, and the horizontal line inside the box is the median. The ends of the whiskers represent the minimum and maximum of all of the data. Each individual MBL value is depicted as a point disease processes. However, subnormal levels are also found in healthy people. There is, therefore, no consensus on the clinical relevance of MBL deficiency or its treatment. It is yet unclear how MBL deficiency could lead to abnormal pregnancy outcomes. The role of native immunity has been discussed in the pathogenesis of preterm birth. There are complex pathways at the maternofetal interface between foetal trophoblast cells and maternally derived cells, which are biased in favour of Th2-type responses. This microenvironment creates a tolerogenic niche to facilitate the development of the semiallogeneic foetus. Perturbations in the fetomaternal immune cross-talk seem to play a role in pregnancy complications. 30 ,31 MBL and other collectins, which are present in gestational tissues during pregnancy, are likely to be important regulators of fetomaternal interactions as they can alter mother's immune response to the allogenic foetus. Pregnancy is thus affected by the native maternal immune system and its interactions with the foetus. 7 In addition, recent studies suggest that the foetus does not develop in a completely sterile environment, and the pregnancy outcome is thus dependant on the interaction between the maternal immune system, the fetoplacental unit and the maternal microbiome in the womb and other tissues. 4, 32, 33 We speculate that the association between low levels of MBL and the incidence of prematurity can be related to the maternal microbial colonization of the birth canal. The pregnancy outcome may thus depend on individual interactions of maternal and foetal immune system with these micro-organisms. Kindinger et al 34 reported that the dominance of Lactobacillus iners in the vaginal microbiota at 16 weeks of gestation is a risk factor for preterm birth, whereas L. crispatus dominance is protective against preterm birth. Similar observations were reported by Prince et al 4 who analysed differences in placental microbiome in association with preterm birth and chorioamnionitis. They reported increased presence of Lactobacillus crispatus in placentas from term deliveries, compared to preterm placentas. In preterm patients, the placental microbiome consisted of a wide spectrum of micro-organisms, including urogenital micro-organisms (eg Ureaplasma, Streptococcus agalactiae), as well as oral commensal bacteria (eg Fusobacterium species and Streptococcus thermophilus). Interestingly, administration of betamethasone or antibiotics had no observable impact on these results. 4 MBL has been detected in the cervico-vaginal cavity where it can provide a first-line defence against infectious agents colonizing the lower tract of the reproductive system. 35 There is not much information available regarding the levels of MBL during physiological pregnancy. Van de Geijn 20 reported increased serum MBL concentrations during pregnancy, compared to pre-pregnant levels. Wang et al investigated whether low second trimester concentrations of MBL could be predictive of preterm labour. They found no significant differences in the levels of MBL between term and preterm patients during second trimester. However, among mothers with term pregnancies, the MBL plasma levels increased significantly from the second trimester to delivery, whereas in mothers who delivered preterm the MBL levels did not change. 25 In contrast, Thevenon et al 36 reported relatively constant concentrations of MBL throughout pregnancy. There is no clear consensus in the literature as to the role of MBL in preterm labour and other pregnancy pathologies. Future studies are likely to explore the interaction of the maternal immune system with its microbiome, and how this can lead to preterm labour, particularly in the presence of underlying abnormalities of the native or acquired immune system. Progesterone is the most effective therapeutic remedy for preterm birth thus far. Progesterone-mediated immunomodulation is one of the mechanisms that enables maintenance and stabilization of pregnancy. [37] [38] [39] Bulla studied the expression levels of MBL in the cervico-vaginal lavage samples in healthy cycling women, and found higher concentrations in the secretory phase of the cycle, suggesting MBL production is progesterone-dependent. 35 This suggests a possible mechanism through which progesterone regulates native immunity.
| CONCLUSION
Preterm birth affects a high proportion of the population worldwide. Current research largely concentrates on the role of the immune system in the pathogenesis of preterm labour. The complement system is an important player of the native immune system, and MBL is one of its activating proteins. There is no clear consensus about the role of MBL in preterm birth; however, our small cohort study found a strong association between MBL deficiency and preterm delivery, and associated low birthweight. In addition, there was a high risk of chorioamnionitis and funisitis in MBL deficient patients. MBL deficiency could thus be considered an important risk factor for preterm birth. We speculate that future studies will explore the interactions between the maternal immune system and her microbiome during pregnancy. 
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